Taipei, Taiwan

Mei-Shey Lin

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Development Center for Biotechnology. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mei-Shey Lin. Retrieved from https://idiyas.com/inventor/mei-shey-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Mei-Shey Lin in Pharmaceutical Chemistry

Introduction

Mei-Shey Lin is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry. His work primarily focuses on the development of novel compounds that have potential therapeutic applications.

Latest Patents

Mei-Shey Lin holds a patent for "1,2,3,4-tetrahydroisoquinoline derivatives and pharmaceutical." This invention relates to compounds of formula (I) wherein R¹ is an optional substituent at any position of the phenyl ring. The substituents are selected from halogen, --NO₂, --NH₂, --OH, and --O--CR₁-₆ alkyl. This patent showcases his innovative approach to creating new pharmaceutical compounds.

Career Highlights

Mei-Shey Lin is associated with the Development Center for Biotechnology. His work at this institution has allowed him to explore various aspects of drug development and contribute to advancements in the field.

Collaborations

Mei-Shey Lin has collaborated with notable colleagues, including Hsiang-Ling Huang and Ya-Chuan Lin. These collaborations have fostered a productive environment for research and innovation.

Conclusion

Mei-Shey Lin's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…